FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898382045> ?p ?o ?g. }

• W2898382045 endingPage "S774" @default.
• W2898382045 startingPage "S774" @default.
• W2898382045 abstract "Many patients diagnosed with lung cancer continue to smoke even though this can make treatment less effective and increase side effects. E-cigarettes form part of the UK’s tobacco harm reduction policy landscape and are smokers’ most popular quit attempt method. This pilot study explores feasibility and acceptability of e-cigarettes to aid smoking cessation among lung cancer patients with advanced disease undergoing chemotherapy. mokers with Stage IV lung cancer were recruited in NHS Greater Glasgow and Clyde and NHS Lanarkshire. Participants were provided with a 2nd generation e-cigarette device and a four week supply of e-liquid. A baseline home visit was conducted by a researcher and an experienced e-cigarette user. Participants were followed-up over 16 weeks. We explored participants' experiences of using e-cigarettes including CO validated smoking cessation at 4 and 16 weeks. Qualitative interviews were conducted with participants (n=13), their significant others (n=6) and health professionals (n=8) engaged with lung cancer patients to obtain their views on the study. Twenty-nine patients were recruited and completed baseline data collection. Three patients died during the study. Of the 26 remaining, 35% (n=9) were CO validated as having stopped smoking at four weeks and 15% (n=4) at 16 weeks. Study procedures were viewed as feasible and acceptable. Patients’ experiences of using e-cigarettes were mixed. Some felt unwell during treatment making stopping smoking more challenging. Those who managed to quit were very positive about e-cigarettes as were their significant others. Health professionals expressed concern about longer term e-cigarette safety but welcomed the study. Smoking cessation should be offered to patients who have incurable disease. It is feasible and acceptable to offer e-cigarettes for smoking cessation to lung cancer patients during treatment. Cessation outcomes were positive and comparable with local cessation services. Future research involving a pilot randomised controlled trial is warranted but should include patients with less advanced cancer and assessment of longer term outcomes" @default.
• W2898382045 created "2018-11-02" @default.
• W2898382045 creator A5010619018 @default.
• W2898382045 creator A5026599300 @default.
• W2898382045 creator A5030840846 @default.
• W2898382045 creator A5032112045 @default.
• W2898382045 creator A5034873959 @default.
• W2898382045 creator A5080160426 @default.
• W2898382045 creator A5081690771 @default.
• W2898382045 date "2018-10-01" @default.
• W2898382045 modified "2023-10-03" @default.
• W2898382045 title "P2.10-03 Feasibility and Acceptability of E-Cigarettes as an Aid to Quitting Smoking in Lung Cancer Patients: A Pilot Study" @default.
• W2898382045 doi "https://doi.org/10.1016/j.jtho.2018.08.1332" @default.
• W2898382045 hasPublicationYear "2018" @default.
• W2898382045 type Work @default.
• W2898382045 sameAs 2898382045 @default.
• W2898382045 citedByCount "0" @default.
• W2898382045 crossrefType "journal-article" @default.
• W2898382045 hasAuthorship W2898382045A5010619018 @default.
• W2898382045 hasAuthorship W2898382045A5026599300 @default.
• W2898382045 hasAuthorship W2898382045A5030840846 @default.
• W2898382045 hasAuthorship W2898382045A5032112045 @default.
• W2898382045 hasAuthorship W2898382045A5034873959 @default.
• W2898382045 hasAuthorship W2898382045A5080160426 @default.
• W2898382045 hasAuthorship W2898382045A5081690771 @default.
• W2898382045 hasBestOaLocation W28983820451 @default.
• W2898382045 hasConcept C121608353 @default.
• W2898382045 hasConcept C126322002 @default.
• W2898382045 hasConcept C142724271 @default.
• W2898382045 hasConcept C1862650 @default.
• W2898382045 hasConcept C2776256026 @default.
• W2898382045 hasConcept C2777843972 @default.
• W2898382045 hasConcept C3018997237 @default.
• W2898382045 hasConcept C512399662 @default.
• W2898382045 hasConcept C71924100 @default.
• W2898382045 hasConceptScore W2898382045C121608353 @default.
• W2898382045 hasConceptScore W2898382045C126322002 @default.
• W2898382045 hasConceptScore W2898382045C142724271 @default.
• W2898382045 hasConceptScore W2898382045C1862650 @default.
• W2898382045 hasConceptScore W2898382045C2776256026 @default.
• W2898382045 hasConceptScore W2898382045C2777843972 @default.
• W2898382045 hasConceptScore W2898382045C3018997237 @default.
• W2898382045 hasConceptScore W2898382045C512399662 @default.
• W2898382045 hasConceptScore W2898382045C71924100 @default.
• W2898382045 hasIssue "10" @default.
• W2898382045 hasLocation W28983820451 @default.
• W2898382045 hasOpenAccess W2898382045 @default.
• W2898382045 hasPrimaryLocation W28983820451 @default.
• W2898382045 hasRelatedWork W1865944360 @default.
• W2898382045 hasRelatedWork W1982590753 @default.
• W2898382045 hasRelatedWork W2003815175 @default.
• W2898382045 hasRelatedWork W2079861668 @default.
• W2898382045 hasRelatedWork W2108933828 @default.
• W2898382045 hasRelatedWork W2186138706 @default.
• W2898382045 hasRelatedWork W2415574270 @default.
• W2898382045 hasRelatedWork W2415958338 @default.
• W2898382045 hasRelatedWork W2419630039 @default.
• W2898382045 hasRelatedWork W3025053580 @default.
• W2898382045 hasVolume "13" @default.
• W2898382045 isParatext "false" @default.
• W2898382045 isRetracted "false" @default.
• W2898382045 magId "2898382045" @default.
• W2898382045 workType "article" @default.